| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |